Design and evaluation studies on colon specific ciprofloxacin matrix tablets for Inflammatory Bowel Disease treatment

Der Pharmacia Lettre

Volumn 3, Issue 2, 2011, Pages 383-395

  Mallikarjuna Gouda, M ^a   Shyale, Somashekar ^a   Kumar, Putta Rajesh ^a   Shanta Kumar, S M ^a  

^a V L COLLEGE OF PHARMACY   (India)

Author keywords

Ciprofloxacin hydrochloride; In vitro studies and inflammatory bowel disease; Matrix carrier

Indexed keywords

CIPROFLOXACIN; DRUG CARRIER;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG FORMULATION; DRUG GRANULATION; DRUG RELEASE; DRUG STRUCTURE; ENTERITIS; EXCIPIENT COMPATIBILITY; IN VITRO STUDY; MATRIX TABLET; NONHUMAN; REPRODUCIBILITY; TABLET COMPRESSION; TABLET DISINTEGRATION; TABLET FRIABILITY; TABLET HARDNESS; TABLET THICKNESS;

EID: 79955740693     PISSN: None     EISSN: 09755071     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. http://digestive.niddk.nih.gov/ddiseases/pubs/colitis/.
2. http://www.medicinenet.com/ulcerative_colitis/article.htm.
3. http://www.webmd.com/ibd-crohns-disease/ciprofloxacin-for-crohns-disease.
4. http://www.emedmag.com/html/pre/gic/consults/041501.asp.
5. Cummings JH, Macfarlane GT, Macfarlane S. Curr. Issues Intest. Microbiol. 2003; 4: 09-20.
6. Moffat AC, Osselton MD, Widdop B. Clarke's analysis of drug and poison. 3rd ed. London: Pharmaceutical Press; 2004; 3: 111.
7. http://www.drugbank.ca/drugs/DB00537 accessed on 14/12/2009.
8. Abdul W. Basit, Michael D. Short, Emma L. McConnell. Journal of Drug Targeting. 2009; Vol. 17, 64-71.
9. Singhal AK, Nalwaya N, Edwin Jarald E, Showkat Ahmed. Colon targeted curcumin delivery using guar gum. 2010; Vol 2 (2) 82-85.
10. Chickpetty SM, Raga baswaraj, Nanjwade BK. Asian journal of pharmaceutical and clinical research. 2010; vol.3 (2), 110-113.
11. Kishore G, Somashekar Shyale Srikanth K, Gupta V.R.M. Journal of Pharmaceutical Science and Technology. 2010; 2 (8): 269-275.
12. Sonia Gupta, Pms Bedi, Neena Bedi. International Journal of Applied Pharmaceutics. 2010; 2(1)
13. Surajit Das, Anumita Chaudhury, Ka-Yun Ng. International Journal of Pharmaceutics. 2010.
14. Lai. HM, Lin. K, Zhang. WB, Zhang. ZR, He. Q. Drug Development and Industrial Pharmacy. 2010; 36(1): 81-92.
15. Krishnaiah Y. S. R, Veer Raju P, B. Dinesh Kumar, Bhaskar P and Satyanarayana V. Journal of Controlled Release. 2001; Vol 77(1-2), 87-95.
16. http://www.pharmacopeia.cn.
17. http://www.pharmacopeia.cn.
18. Mina Ibrahim Tadros. European Journal of Pharmaceutics and Biopharmaceutics. 2010, 74, 332.
19. Putta Rajesh Kumar; Rajesh Tatavarthi; M Mallikarjuna Gouda; Somashekar Shyale and SM Shanta Kumar. International Journal of Pharmaceutical Sciences Review and Research. 2011, 6, 56.
20. Yagnesh Bhatt; Anand Deshmukh; Maulesh Joshi; Suhas Nalle and Raviprakash Paladi. Int. J. Ph. Sci. 2009, 1, 310.
21. Indian pharmacopoeia, The Indian pharmacopoeia commission, Ghaziabad. 2007; 3 ed, vol-1: pp 177-178.
22. Singh Chhater; Kumar Rajesh; Agarwal Kshitij and RK Nema. International journal of pharmaceutical sciences and nanotechnology. 2009, 2, 443.
23. Della Grace Thomas Parambi, Molly Mathew, Anila Jose, Revikumar KG. International Journal of Pharmaceutical Sciences Review and Research. 2010; 3 (2): 139-141.
24. Krishnaiah Y.S.R, Satyanarayana. S, Rama Prasad Y.V, Narasimha Rao. S. International Journal of Pharmaceutics. 1998; (171): 137-146.